Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tania Crombet Ramos, Pedro Camilo Rodríguez, Elia Neninger Vinageras, Beatriz Garcia Verdecia & Agustin Lage Davila. (2015) CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer. Expert Review of Vaccines 14:10, pages 1303-1311.
Read now
Read now
Articles from other publishers (15)
Yuan Liang, Tiehua Zhang & Jie Zhang. (2020) Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy. Pharmacological Research 161, pages 105164.
Crossref
Crossref
Tiehua Zhang, Yuan Liang, Peng Zuo, Siyuan Jing, Tiezhu Li, Yongjun Wang, Chengyu Lv, Da Li, Jie Zhang & Zhengyi Wei. (2020) 20(S)-Protopanaxadiol blocks cell cycle progression by targeting epidermal growth factor receptor. Food and Chemical Toxicology 135, pages 111017.
Crossref
Crossref
Rintu Thomas & Zhang Weihua. (2019) Rethink of EGFR in Cancer With Its Kinase Independent Function on Board. Frontiers in Oncology 9.
Crossref
Crossref
Feifei Zhang, Shana Qin, Xiang Xiao, Yuefa Tan, Peng Hao & Yikai Xu. (2019) Overexpression of LIMD2 promotes the progression of non‑small cell lung cancer. Oncology Letters.
Crossref
Crossref
Jana Fassunke, Michaela Angelika Ihle, Dido Lenze, Annika Lehmann, Michael Hummel, Claudia Vollbrecht, Roland Penzel, Anna-Lena Volckmar, Albrecht Stenzinger, Volker Endris, Andreas Jung, Ulrich Lehmann, Silke Zeugner, Gustavo Baretton, Hans Kreipe, Peter Schirmacher, Thomas Kirchner, Manfred Dietel, Reinhard Büttner & Sabine Merkelbach-Bruse. (2017) EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial. Virchows Archiv 471:4, pages 509-520.
Crossref
Crossref
Ahmad A. Zulkifli, Fiona H. Tan, Tracy L. Putoczki, Stanley S. Stylli & Rodney B. Luwor. (2017) STAT3 signaling mediates tumour resistance to EGFR targeted therapeutics. Molecular and Cellular Endocrinology 451, pages 15-23.
Crossref
Crossref
Sara Mariani, Luca Bertero, Simona Osella-Abate, Cristiana Di Bello, Paola Francia di Celle, Vittoria Coppola, Anna Sapino, Paola Cassoni & Caterina Marchiò. (2017) Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene. British Journal of Cancer 117:3, pages 358-366.
Crossref
Crossref
Nora Berois, Diego Touya, Luis Ubillos, Bernardo Bertoni, Eduardo Osinaga & Mario Varangot. (2017) Prevalence of EGFR Mutations in Lung Cancer in Uruguayan Population. Journal of Cancer Epidemiology 2017, pages 1-9.
Crossref
Crossref
Xucheng Yang, Pengfei Lei, Yong Huang, Zijian Zhang & Yingying Zhang. (2016) MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1. Oncology Letters 12:5, pages 3619-3625.
Crossref
Crossref
Tareq Saleh, Laurie Cuttino & David A. Gewirtz. (2016) Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:10, pages 2130-2136.
Crossref
Crossref
Charli Dominguez, Kwong-Yok Tsang & Claudia Palena. (2016) Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies. Cell Death & Disease 7:9, pages e2380-e2380.
Crossref
Crossref
Xuefeng Zhou, Jialong Guo, Yanmei Ji, Gaofeng Pan, Tao Liu, Hua Zhu & Jinping Zhao. (2016) Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma. Molecular Cancer Research 14:5, pages 448-457.
Crossref
Crossref
Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya, Michael J. Mitten, Suzanne Norvell, Hugh D. Falls, Peter J. DeVries, Dong Cheng, Jonathan A. Meulbroek, Fritz G. Buchanan, Laura M. McKay, Neal C. Goodwin & Edward B. Reilly. (2016) ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope. Molecular Cancer Therapeutics 15:4, pages 661-669.
Crossref
Crossref
Bryant C. Yung, Jilong Li, Mengzi Zhang, Xinwei Cheng, Hong Li, Elaine M. Yung, Chen Kang, Lauren E. Cosby, Yang Liu, Lesheng Teng & Robert J. Lee. (2016) Lipid Nanoparticles Composed of Quaternary Amine–Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer. Molecular Pharmaceutics 13:2, pages 653-662.
Crossref
Crossref
Jinsong Li, Huayun Deng, Meichun Hu, Yuanzhang Fang, Amanda Vaughn, Xiaopan Cai, Leqin Xu, Wei Wan, Zhenxi Li, Shijie Chen, Xinghai Yang, Song Wu & Jianru Xiao. (2015) Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR. Oncotarget 6:9, pages 6749-6761.
Crossref
Crossref